Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | China Pharmaceutical Chain Industry Report 2009This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry.
By: FriedlNet In 2008, the average profit margin of top 100 enterprises was 3.76%, more 0.76 points than that in 2007 The data of this report come from China Association of Pharmaceutical Commerce, www.pharmnet.com.cn, www.ydzz.com and the National Bureau of Statistics of China. The report makes an in-depth analysis of the operation and future development of pharmaceutical chain industry, guiding investment and financing decision-making. This report includes 8 chapters and 65 diagrams, covering all major aspects and key enterprises in China pharmaceutical chain industry. Chapter 1 introduces the development of China pharmaceutical chain industry briefly. Chapter 2 analyzes the macroeconomic environment, industry environment and policies related with China pharmaceutical chain industry. Chapter 3, 4, 5 analyze operation, competition patterns and key areas of China pharmaceutical chain industry, such as market scale, profitability, competition patterns and regional difference. Chapter 6 analyzes the development trends of China pharmaceutical chain industry. Finally, Chapter 7 analyzes the development, revenue distribution and profitability of over 10 key Chinese pharmaceutical enterprises, including LBX Pharmacy, Nepstar, Hubei Tongjitang, Chongqing Tongjunge Pharmacy, Sinopharm Group Co., Ltd., Chongqing Peace Drugstore. Copyright by FriedlNet.com To get more information, please contact us: Friedl Business Information GmbH Business & Research Center Meldemannstrasse 18/EG08+09 1200 Vienna, Austria Tel: (+43-1) 3218888-0 Fax: (+43-1) 3218888-8 Website: http://www.friedlnet.com Email: rc@friedlnet.com # # # FriedlNet provide China-based information to the professional community and medium, including digital and printed publications, research reports and industry analysis, information services, as well as ready-made and customized directories and databases. End
Account Email Address Disclaimer Report Abuse
|
|